| 造血干细胞移植患者肌少症管理的研究进展 |
| |
| 引用本文： | 叶梦华,徐敏. 造血干细胞移植患者肌少症管理的研究进展[J]. 中华护理杂志, 2021, 56(10): 1595-1600. DOI: 10.3761/j.issn.0254-1769.2021.10.025 |
| |
| 作者姓名： | 叶梦华 徐敏 |
| |
| 作者单位： | 310053 杭州市 浙江中医药大学护理学院（叶梦华）;浙江中医药大学附属第一医院医院管理办公室（徐敏） |
| |
| 基金项目： | 浙江省中医药优秀青年人才基金项目(2021ZQ038) |
| |
| 摘 要： | 造血干细胞移植是目前治疗恶性及非恶性难治性血液病的有效方法。肌少症是造血干细胞移植患者严重的并发症之一,影响患者的康复及预后。该文介绍了肌少症的筛查与评估方法,综述了造血干细胞移植患者肌少症的危险因素及常用的非药物干预方法,并提出相关管理建议,旨在为临床医护人员针对造血干细胞患者进行肌少症的前期预防、早期发现、及时干预提供参考。
|
| 关 键 词： | 造血干细胞移植 肌少症 危险因素 非药物干预 综述 护理 |
| 收稿时间： | 2021-04-19 |
Research progress of sarcopenia management in patients with hematopoietic stem cell transplantation |
| |
| YE Menghua,XU Min. Research progress of sarcopenia management in patients with hematopoietic stem cell transplantation[J]. Chinese Journal of Nursing, 2021, 56(10): 1595-1600. DOI: 10.3761/j.issn.0254-1769.2021.10.025 |
| |
| Authors: | YE Menghua XU Min |
| |
| Abstract: | Hematopoietic stem cell transplantation（HSCT） is an effective therapy for the treatment of malignant and non-malignant refractory hematopathy. Sarcopenia is one of the serious complications in HSCT patients,which affects the recovery and prognosis of the patients. This article reviews the screening and assessment of sarcopenia,analyses the risk factors of sarcopenia in HSCT patients and the current common non-pharmacological interventions,then makes recommendations for sarcopenia management,aiming to provide references for clinical medical staff to carry out early prevention,early detection and timely intervention for such patients. |
| |
| Keywords: | Hematopoietic Stem Cell Transplantation Sarcopenia Risk Factors Non-Pharmacological Interventions Review Nursing Care |
|
| 点击此处可从《中华护理杂志》浏览原始摘要信息 |
|
点击此处可从《中华护理杂志》下载全文 |
